Top section
Top section
Markets will lose their bearings without reliable, independent government data
European stocks have outperformed but IPOs have lagged
Cell and gene therapy company plans US expansion
More articles
More articles
More articles
-
Lossmaking Swiss solar cell manufacturer is scaling back production in Europe, opening in US -
Venkat wants to generate higher returns in investment banking without increasing its capital
-
Saudi Aramco follow-on could hit $20bn
-
The latest privatisation in the Emirate is expected to launch as soon as next week
-
HSBC takes a hit on its Chinese bank stake, while banking, capital markets and advisory revenues remained unscathed
-
Lectra's earnings have suffered from a weak commercial backdrop
Sub-sections
shared comment list
